Home › NDC Lookup › Ingredients › Fexofenadine Hydrochloride › 55111-0783-01
Fexofenadine hydrochloride 60 mg Tablet, 100-count — NDC 55111-0783-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Fexofenadine hydrochloride 60 mg Tablet, 100-count — NDC 55111-783-01 (Billing 55111-0783-01)

by Dr. Reddy's Laboratories Limited · 100 TABLET in 1 BOTTLE

This is a package of 100 tablets of Fexofenadine hydrochloride 60 mg Tablet from Dr. Reddy's Laboratories Limited, marketed since Jan 2011 and currently FDA-listed; retail pharmacies pay about $0.1529 per tablet (NADAC). It is the main listing for this product, which comes in 8 package sizes.

NDC 55111-0783-01
🏷️ FDA NDC (as labeled) 55111-783-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.1529 NADAC Per package$15.29 / 100 tablets Pack sizes8 compare ↓
Also priced by: Medicaid pays $0.2491/unit — full pricing hub ↓
Main listing for product 55111-783 · Also comes in: 12 tablets 55111-783-28 24 tablets 55111-783-24 30 tablets 55111-783-30 60 tablets 55111-783-60 90 tablets 55111-783-90 100 tablets 55111-783-78 4000 tablets 55111-783-94
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 55111-783-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
55111 labeler · 783 product · 01 package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 5511178301 5
Medicaid fills, this package
37,722 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 55111-783-01
Product NDC 55111-783
11-digit billing NDC 55111078301
NCPDP billing unit EA — each (per item)
RxCUI 997420, 997488, 997501
UNII 2S068B75ZU
Application # ANDA076502
SPL Set ID 864e3052-5787-bf11-9d17-11274ca2304f
Established class (EPC) Histamine-1 Receptor Antagonist
Mechanism of action Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2011-01-03
Route ORAL
Dosage form TABLET
Substance FEXOFENADINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 41550024100320
GCN Seq No 031689
GCN 46593
HICL code 011595
Ingredient (HICL) Fexofenadine Hcl
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2Q
Therapeutic class — specific (HIC3) Antihistamines - 2Nd Generation
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name FEXOFENADINE HCL 60 MG TABLET
FDB brand name Fexofenadine Hcl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 031689
  • GCN: 46593
  • GPI-14 (Medi-Span): 41550024100320
  • HICL (First Databank): 011595
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 997420
Why two NDCs? The FDA registers this code as 55111-783-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 55111-0783-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Other antihistamines for systemic use
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FEXOFENADINE HCL 60 MG TABLET Ingredient Fexofenadine Hcl
📖 What it is MedlinePlus · NLM

Fexofenadine is used to treat allergy symptoms: runny nose sneezing red, itchy, or watering eyes itching of the nose or throat It is also used to treat itching and redness caused by hives. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves hay fever and other upper respiratory allergy symptoms like runny nose, sneezing, and itchy, watery eyes. Some products, like Allegra Hives 24hr, are for hives and the...
  • No. The label says not to take it with fruit juices, so use water instead. Also avoid taking it at the same time as aluminum or magnesium antacids.
  • Can I take fexofenadine with fruit juice?
  • Yes, check with your doctor first. The label says your doctor should decide whether you need a different dose. The same goes for adults 65 and older.
📖 Read our full Fexofenadine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.153 $15.29 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.2491 $24.91 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.187 $0.140
▲ Up 8% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
55111-0783-01 You're viewing this Main listing 100 TABLET in 1 BOTTLE $0.1529 / ea $15.29 2011-01-03 — Active
55111-0783-24 55111-783-24 4 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK — — 2020-12-01 — Active
55111-0783-28 55111-783-28 2 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK — — 2020-12-01 — Active
55111-0783-30 55111-783-30 30 TABLET in 1 BOTTLE — — 2011-01-03 — Discontinued by firm
55111-0783-60 55111-783-60 60 TABLET in 1 BOTTLE — — 2011-01-03 — Active
55111-0783-78 55111-783-78 10 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK — — 2011-01-03 — Active
55111-0783-90 55111-783-90 90 TABLET in 1 BOTTLE — — 2011-01-03 — Active
55111-0783-94 55111-783-94 4000 TABLET in 1 POUCH — — — — Active

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle.
How does this package differ from NDC 55111-0783-28?
Both are Fexofenadine hydrochloride 60 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 55111-0783-28 is the 12 tablets package.
What NDC number is used to bill for this package of Fexofenadine hydrochloride 60 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
fexofenadine hcl 60 mg 00904-7192-40 Major 500 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mgthis 55111-0783-01 Dr. 100 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mg 68001-0439-00 BluePoint 100 tablets $0.153 — Availability likely —
Fexofenadine HCl 60 mg 69230-0201-05 Camber 500 tablets $0.153 — Availability likely —
12HR Allergy Relief 60 mg 70000-0586-01 CARDINAL 12 tablets $0.153 — Availability likely —
Allergy Relief 60 mg 70677-1008-01 Strategic 24 tablets $0.153 — Discontinued —
Allergy Relief 60 mg 83324-0009-12 Chain 12 tablets $0.153 — Availability likely —
Fexofenadine hydrochloride 60 mg 00363-0783-24 Walgreens 24 tablets — — FDA listed —
Fexofenadine HCL 60 mg 00363-9765-24 Walgreens 24 tablets — — FDA listed —
Fexofenadine HCl 60 mg 11822-7652-04 Rite 24 tablets — — FDA listed —
Allergy Relief 60 mg 11822-9995-01 Rite 24 tablets — — Discontinued —
Fexofenadine Hydrochloride 60 mg 30142-0091-12 Kroger 12 tablets — — Discontinued —
Allergy Relief 60 mg 37808-0391-02 HEB 12 tablets — — FDA listed —
Allegra Allergy 60 mg 41167-4131-02 Chattem, 12 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 43598-0936-01 Dr. 100 tablets — — FDA listed —
fexofenadine hcl 60 mg 50228-0201-01 ScieGen 30 tablets — — FDA listed —
Crcle Fexofenadine Hydrochloride 60 mg 57483-0230-01 Innovus 100 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 62207-0765-49 Granules 1000 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 62207-0889-49 Granules 1000 tablets — — FDA listed —
Allergy Relief 60 mg 63548-0663-05 PLD 500 tablets — — FDA listed —
Allergy Relief 60 mg 63868-0819-12 Chain 12 tablets — — Discontinued —
Allergy Relief Non Drowsy 60 mg 69168-0437-06 Allegiant 120 tablets — — FDA listed —
Fexofenadine HCL 60 mg 69230-0301-01 Camber 100 tablets — — FDA listed —
Allergy Relief 60 mg 69842-0492-02 CVS 12 tablets — — FDA listed —
fexofenadine hcl 60 mg 71335-2165-01 Bryant 30 tablets — — FDA listed —
fexofenadine hcl 60 mg 71399-8659-01 AKRON 100 tablets — — FDA listed —
Allergy Relief 60 mg 72036-0191-03 HARRIS 288 tablets — — FDA listed —
Gencare-Allergy Relief 60 mg 72090-0068-01 Pioneer 100 tablets — — FDA listed —
Fexofenadine HCL 60 mg 73581-0010-01 YYBA 10 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 73581-0025-01 YYBA 10 tablets — — FDA listed —
Allergy Relief 60 mg 73581-0103-10 YYBA 100 tablets — — FDA listed —
fexofenadine hcl 60 mg 77771-0201-01 Radha 100 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 84324-0045-01 NUVICARE 60 tablets — — FDA listed —
Fexofenadine Hydrochloride 60 mg 58602-0877-09 Aurohealth 30 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2011
On the market since
Jan 2011
📍
2026
Currently FDA-listed
15 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Pink
ShapeOval
Imprint194;R
Size7 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Fexofenadine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 0WZ8WG20P6
    Hypromellose 2910 is a plant-based cellulose derivative that acts as a thickener, binder, and film-coating agent. It helps control how quickly the medicine dissolves and protects the tablet or capsule from moisture and light.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII SMD1X3XO9M
    Powdered cellulose is a fine, plant-based powder made from purified wood fibers. In medicines, it acts as a filler to add bulk and volume, and helps tablets or capsules hold together during manufacturing and storage.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescolloidal silicon dioxide, corn starch, croscarmellose sodium, FD&C Red no. 40, hypromellose, iron oxide black, magnesium stearate, mannitol, polyethylene glycol, powder cellulose and titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDr. Reddy's Laboratories Limited
Application holderDR REDDYS LABORATORIES LTD
FDA applicationANDA076502 (ANDA)
Labeler code55111
First marketedJan 2011
Product typeHuman Otc Drug
Portfolio200 products on file

More NDCs from Dr. Reddy's Laboratories Limited labeler code 55111

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

⏱️ Dosage and Administration 197 words ▾

Directions 30 mg adults and children 12 yearsof age and over take two 30 mg tablets with water every 12 hours; do not take more than 4 tablets in 24 hours children 6 to under 12 years of age take one 30 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours children under 6 years of age do not use Adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor 60 mg: adults and children 12 years of age and over take one 60 mg tablet with water every 12 hours; do not take morethan 2 tablets in 24 hours children under 12 years of age do not use Adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor 180 mg: adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than1 tablet in 24 hours children under 12 years of age do not use Adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

⚠️ Warnings 119 words ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions) Stop use and ask doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 17 words ▾

Active ingredient(s) Fexofenadine HCl USP, 30 mg Fexofenadine HCl USP, 60 mg Fexofenadine HCl USP, 180 mg

🧪 Inactive Ingredients 27 words ▾

Inactive ingredients colloidal silicon dioxide, corn starch, croscarmellose sodium, FD&C Red no. 40, hypromellose, iron oxide black, magnesium stearate, mannitol, polyethylene glycol, powder cellulose and titanium dioxide

🎯 Purpose 2 words ▾

Purpose Antihistamine

📄 Do Not Use 19 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

📄 Ask a Doctor Before Use If 20 words ▾

Ask a doctor before use if you have kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 30 words ▾

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions)

📄 Stop Use and Ask a Doctor If 18 words ▾

Stop use and ask doctor if an allergic reaction to this product occurs. Seek medical help right away.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 3 words ▾

Questions? Call 1-888-375-3784

📄 Package Label / Principal Display Panel 22 words ▾

PACKAGE LABEL PRINCIPAL DISPLAY PANEL SECTION 180 mg Container:

30 mg Carton:

60 mg Carton:

60 mg Container:

180 mg Carton Label:

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
37.7K
Units reimbursed last 4 qtrs
1.9M
Gross reimbursed last 4 qtrs
$475.1K
Avg / prescription
$12.59
Avg / unit
$0.2491
Latest quarter Q1 2026
6.5KRx
Medicaid pays / ea
$0.2491
gross reimbursed
vs
NADAC / ea
$0.1529
acquisition cost
=
Spread
+$0.0962
+63% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
49% FFS 51% MCO
Fee-for-service · 18,396 Rx Managed care · 19,326 Rx
State Medicaid map
Alaska: 3,885 units · 530 per 100k residents AK Maine: 2,340 units · 168 per 100k residents ME Washington: no data reported WA Idaho: 5,448 units · 277 per 100k residents ID Montana: 3,774 units · 333 per 100k residents MT North Dakota: no data reported ND Minnesota: 47,361 units · 826 per 100k residents MN Wisconsin: 8,020 units · 136 per 100k residents WI Michigan: 66,232 units · 660 per 100k residents MI New York: 331,513 units · 1,694 per 100k residents NY Vermont: 4,854 units · 750 per 100k residents VT New Hampshire: 9,972 units · 711 per 100k residents NH Oregon: 21,576 units · 510 per 100k residents OR Nevada: 7,169 units · 224 per 100k residents NV Wyoming: 3,337 units · 571 per 100k residents WY South Dakota: 2,339 units · 255 per 100k residents SD Iowa: no data reported IA Illinois: 50,974 units · 406 per 100k residents IL Indiana: 49,153 units · 716 per 100k residents IN Ohio: 83,130 units · 705 per 100k residents OH Pennsylvania: 129,316 units · 998 per 100k residents PA New Jersey: 28,245 units · 304 per 100k residents NJ Massachusetts: 25,622 units · 366 per 100k residents MA California: 505,797 units · 1,298 per 100k residents CA Utah: no data reported UT Colorado: 4,396 units · 74.8 per 100k residents CO Nebraska: 3,162 units · 160 per 100k residents NE Missouri: 10,159 units · 164 per 100k residents MO Kentucky: 108,267 units · 2,392 per 100k residents KY West Virginia: 38,774 units · 2,191 per 100k residents WV Virginia: 18,642 units · 214 per 100k residents VA Maryland: 46,620 units · 754 per 100k residents MD Connecticut: 7,301 units · 202 per 100k residents CT Rhode Island: 3,438 units · 314 per 100k residents RI Arizona: 58,744 units · 791 per 100k residents AZ New Mexico: 26,289 units · 1,244 per 100k residents NM Kansas: 34,675 units · 1,179 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: 7,520 units · 69.4 per 100k residents NC South Carolina: 17,024 units · 317 per 100k residents SC Delaware: 2,823 units · 274 per 100k residents DE Oklahoma: no data reported OK Louisiana: 3,621 units · 79.2 per 100k residents LA Mississippi: no data reported MS Alabama: 38,308 units · 750 per 100k residents AL Georgia: 55,359 units · 502 per 100k residents GA D.C.: 2,117 units · 312 per 100k residents DC Hawaii: 9,438 units · 658 per 100k residents HI Texas: 12,833 units · 42.1 per 100k residents TX Florida: 7,913 units · 35.0 per 100k residents FL
Units reimbursed · per 100k residents
35.02,392
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 2,392 /100k
2 West Virginia 2,191 /100k
3 New York 1,694 /100k
4 California 1,298 /100k
5 New Mexico 1,244 /100k
6 Kansas 1,179 /100k
7 Pennsylvania 998 /100k
8 Minnesota 826 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 tablets this page55111-0783-01 37,722 Rx · $475,062
30 tablets55111-0783-30 16 Rx · $86
24 tablets55111-0783-24 No Medicaid data
12 tablets55111-0783-28 No Medicaid data
60 tablets55111-0783-60 No Medicaid data
100 tablets55111-0783-78 No Medicaid data
90 tablets55111-0783-90 No Medicaid data
4000 tablets55111-0783-94 No Medicaid data
Drug total (last 4 qtrs): 37,738 Rx · 1,908,278 units · $475,148 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Fexofenadine hydrochloride — the ingredient across all brands.

Top reported reactions

Headache969
Fatigue954
Pruritus911
Nausea857
Diarrhoea766
Extra Dose Administered722
Dizziness720

Age at onset

Neonate6
Infant8
Child193
Adolescent247
Adult7,080
Elderly2,710

Reporter sex

21,660 reports
Male · 31%
Female · 69%
Unknown · 0%

Serious outcomes

Hospitalization2,929
Death693
Life-threatening353
Disabling346
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 2,118 1,274
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 55111-0782-01 · Dr. 55111-0784-01 · Dr. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.